Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovator Spotlight: Innovation Through Partnerships Is In Omron Healthcare's Blood

Executive Summary

This year, Omron Healthcare launched its new HeartGuide smartwatch and the first FDA-cleared blood pressure monitor with EKG capability. Medtech Insight sat down with Omron's CEO Ranndy Kellogg to learn about upcoming plans.

You may also be interested in...



Roundup: XMed2019: 7 Innovators To Watch

Medtech Insight features its shortlist of top innovators who showcased their products at the recent Exponential Medicine conference in San Diego.

Expert Panel Discusses Trends In Digital Health Investment

An expert panel at the AdvaMed MedTech Conference in San Francisco discussed trends in digital health investment including market opportunities and regulatory and reimbursement challenges.

Livongo Buys Behavioral Health Firm In Multimillion Dollar Deal, Plans To Hire 300-500 People

Livongo, which developed a digital platform for managing chronic conditions, announced Jan. 30 it acquired myStrength, a Denver-based digital behavioral health company. The company didn’t disclose financial details, but Livongo's executive chairman Glen Tullman told Medtech Insight the acquisition cost was in the "tens of millions of dollars."

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel